
Business in Brief: Teva Shares Drop After Rival Reports Progress on Alternative Multiple Sclerosis Drug
Shares of Teva Pharmaceuticals fall after a company develops a competitor to the Copaxone multiple sclerosis drug ■ IceCure Medical received approval to use extreme cold to destroy tumors ■ Tel Aviv shares ended lower for a third day
comments
Print
Want to enjoy 'Zen' reading - with no ads and just the article? Subscribe today
Subscribe now